Has John Ebner, DO received payments from drug or device companies?

Yes. Drug and device makers reported $26,104 in general payments to John Ebner, DO across 1,416 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Ebner, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Ebner, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Ebner, DO

MOHS-Micrographic Surgery · Phoenix, AZNPI 1295927788

Payments from drug & device makers

$26,104in general payments, 2019–2025

Across 1,416 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$5K
Novartis$3K
Amgen$2K
LEO Pharma Inc.$2K
Sun Pharmaceutical Industries Inc.$2K
Johnson & Johnson$2K
plus $11K from 33 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	231	$4,559
Novartis	210	$3,206
Amgen	57	$1,928
LEO Pharma Inc.	105	$1,921
Sun Pharmaceutical Industries Inc.	95	$1,812
Johnson & Johnson	140	$1,753
UCB, Inc.	68	$1,276
Ortho Dermatologics, A Division Of Bausch Health US, LLC	51	$1,240
Lilly USA, LLC	48	$875
Genentech USA, Inc.	33	$764
Sanofi	31	$758
Regeneron Healthcare Solutions, Inc.	23	$720
Pfizer	52	$655
E.r. Squibb & Sons, L.L.C.	36	$563
Regeneron	2	$526
Dermavant Sciences, Inc.	53	$466
Arcutis Biotherapeutics, Inc.	34	$400
Incyte Corporation	19	$363
Biofrontera Inc.	16	$298
VYNE Pharmaceuticals Inc.	11	$296
Kyowa Kirin, Inc.	12	$287
Bristol Myers Squibb	6	$275
Organon	25	$228
Organogenesis Inc.	12	$163
Botanix SB Inc	11	$152
Boehringer Ingelheim	3	$90
Helsinn Therapeutics (U.S.), Inc.	6	$89
Galderma Laboratories, L.p.	5	$81
Osiris Therapeutics Inc.	4	$62
Verrica Pharmaceuticals Inc.	2	$49
Smith+Nephew	3	$46
Prugen, Inc. Pharmaceuticals	3	$39
Krystal Biotech Inc	1	$32
Dermira, Inc.	2	$30
Mayne Pharma Commercial LLC	2	$26
Solta Medical, A Division Of Bausch Health US, LLC	1	$23
Mimedx Group, Inc.	1	$21
Sanofi-aventis U.S. LLC	1	$18
Glenmark Therapeutics Inc.	1	$14

How this compares

$26,104 in reported general payments places this provider in the 95th percentile of 38 mohs-micrographic surgery providers in Arizona.

See all mohs-micrographic surgery providers in Arizona →

Medicare billing

Part B allowed, 2024

$1,084,925

Medicare patients

1,050

Services billed

15,723

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other mohs-micrographic surgery in Phoenix

Amena DelucaPhoenix$6K
Yulia KhanPhoenix$3K
James FosheePhoenix$1K
Christine LinScottsdale$49K
Joseph JanikChandler$8K
J Ryan JacksonMesa$6K
Seth GoodmanSun City$6K
Mitchell ManwayScottsdale$6K
Tejaswi MudigondaLake Havasu City$5K
Christopher WeyerSierra Vista$4K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →